Navigation Links
PROMACTA(R) (eltrombopag) RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL
Date:5/30/2008

mentById('headline'); s.tl(this,'o',getLinkName('Company Sanpshot'));" >LGND). It is being developed by GlaxoSmithKline. Eltrombopag is an investigational compound that has not received regulatory approval in any market for any indication at this time.

About GlaxoSmithKline

GlaxoSmithKline -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information, visit GlaxoSmithKline at http://www.gsk.com.

Cautionary statement regarding forward-looking statements

Under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect GSK's operations are described under 'Risk Factors' in the 'Business Review' in the company's Annual Report on Form 20-F for 2007.

Note to Editors

PROMACTA(R) is a registered trademark of GlaxoSmithKline group of companies and is the proposed trade name in the United States.

To access the latest GSK news, visit http://us.gsk.com/

Inquiries:

US Media inquiries: Jeff McLaughlin 1 919 483 2839

Mary Anne Rhyne 1 919 483 2839

Nancy Pekarek 1 215 751 7709

US Analyst/Investor inquiries: Frank Murdolo 1 215 751 7002

Tom Curry 1 215 751 5419

References:

(1) US Food and Drug Administration. The Orphan Drug act (as amended). Accessed May 2008.
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. GlaxoSmithKline Files for FDA Approval of PROMACTA(TM) (eltrombopag) to be the First Oral Platelet Growth Factor for Rare Blood Disorder
2. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
3. DaVita Receives Civil Complaint
4. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
5. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
6. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
7. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
8. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
9. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
10. Prime Therapeutics Receives TIPPS Certification
11. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...ter to chill out. Places such as backyard pool, ho...s should be very for cautious and always follow th... avoid facing dangerous situations parents have ta...e pool fences and pool alarms. But in case of spas...
...ho have also been diagnosed as HIV-positive seemed... their health status to others//. The study, the ...ns who work with HIV-positive men who are often un...y, co-workers or others about being diagnosed with...
...rious medical courses offered by unaided medical i...on and research department// of the Punjab governm... other similar medical and paramedical courses. R...nd students have also been invited for a consultat...
...es become inflamed or infected affecting 37 millio...nal surgery//. But now Acclarent has come up with ...volves inflating a small balloon in the sinus cavi...ed as a major breakthrough that offers hope to man...
Other Medicine News:Health News:Hot Tubs and Spas in the News for Safety Measures 2Health News:Gays Have No Regrets 2Health News:Gays Have No Regrets 3Health News:Provisional Fees For Medical Courses Fixed By Punjab Government 2Health News:Teething Problems of Sinuplasty 2
(Date:8/19/2008)...d to identify molecular,signature of motor neuron ...Newswire/ -- ALS Therapy,Development Institute (AL...biomarker effort using blood samples collected thr... These ongoing projects are part of the,Institute,...sion of genes,and proteins, at the onset of, and t...
(Date:8/19/2008)... -- Vical Incorporated,(Nasdaq: VICL ) today anno...,Institute, a leading European medical university,...Control (SMI), a governmental expert agency, to,ev...ector(R) 2000,needle-free injection system (Biojec...tivalent preventive DNA vaccine against HIV., Pro...
(Date:8/18/2008)...xt time you consider popping a,pill when you have ...eep,instead. A senior psychiatrist at the Scripps ... evidence that taking sleeping pills regularly can...pke, M.D.,s article, based on a compilation of stu... been published in the Journal,of Sleep Research. ...
(Date:8/18/2008)...ife expectancy for people with,Down syndrome, WAS... world of Down,syndrome, ,Mr. C, is a rarity. A re...past 16 years, at seventy, ,Mr. C, has well surpas...own syndrome, currently in the,late fifties, but i..., does,not exhibit clinical symptoms of Alzheimer,...
Breaking Medicine Technology:ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease 2ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease 3Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 2Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 3Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 4Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 5Prescription Sleeping Pill Use Tied to Cancer 2Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 2Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 3Flavor and Vitamins on the Go 15161 1Flavor and Vitamins on the Go 15161 2Visiprise Named One of the Top Manufacturing Technology Providers 15158 1Visiprise Named One of the Top Manufacturing Technology Providers 15158 2Honeywell Expands Aclar 28R 29 Production for Pharmaceutical Industry 15155 1Honeywell Expands Aclar 28R 29 Production for Pharmaceutical Industry 15155 2Honeywell Expands Aclar 28R 29 Production for Pharmaceutical Industry 15155 3Barilla 28R 29 Whole Grain Makes Healthy Eating Easy 15152 1Barilla 28R 29 Whole Grain Makes Healthy Eating Easy 15152 2
...latin Phase 1 Colorectal and Prostate Cancer,Trial...TH SAN FRANCISCO, Calif., May 23, 2007 /PRNewswire...iopharmaceutical company,focused on oncology, toda...platin, the Company,s lead product candidate, in p... presented in a poster,session at the 43rd Annual ...
...ve in Improving Symptoms and Urine Flow, With,Long...May 23, 2007 /PRNewswire-FirstCall/ -- Spectrum,Ph...y and efficacy,data for ozarelix, the Company,s dr... hypertrophy (BPH), at the American Urology,Associ...n Center in,Anaheim, California on Tuesday, May 22...
Other Medicine Technology:Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 2Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 3Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting 4Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 2Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 3Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 4Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 5
1000 L, Racked, Filtered, Pre-sterilized, 100 tips/rack Recommended for 500 and 1000 L pipettes.
Inquire
Finntip Filters are ideal for PCR and other amplification methods, or for any work where aerosol contamination might occur. They are designed for pipetting DNA/RNA solutions, infectious materials, la
Diamond Filter Tips play a critical role in preventing aerosol-borne contamination. Also available sterilized (no need to autoclave) and certified free of detectable RNase, DNase, DNA, RNA, and prote
Medicine Products: